Targeting Mutant Ataxin-3 with Antisense Oligonucleotides can Improve Purkinje Neuron Dysfunction
June 28, 2024
Written by Asmer Aliyeva Edited by Dr. Hannah K Shorrock Antisense Oligonucleotide (ASO) treatment improves Purkinje neuron function regulated by potassium channels and highlights altered brain connectivity in movement disruption in SCA3. Understanding which cell types are important for disease onset is vital for therapy development and treatment options for Read More…
